NCT01577095View on ClinicalTrials.gov

Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Type 2 Diabetes Mellitus With Features of Insulin Resistance
Interventions
OTHER

EA + Rosiglitazone

electroacupuncture and Rosiglitazone combined therapy on patient of type II DM

DRUG

TZD

Rosiglitazone 8 mg single dose

Trial Locations (1)

404

Department of Integrative Chinese-Western Clinic, China Medical University Hospital, Taichung

All Listed Sponsors
lead

China Medical University Hospital

OTHER

NCT01577095 - Evaluating the Effects of Electroacupuncture and Rosiglitazone Combined Therapy | Biotech Hunter | Biotech Hunter